New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Chest
Jeffrey I WeitzMeyer M Samama

Abstract

This article about new anticoagulant drugs is part of the seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. The limitations of existing oral and parenteral anticoagulant agents have prompted a search for novel agents. Focusing on new anticoagulant drugs for the prevention and treatment of arterial and venous thrombosis, this article (1) reviews arterial and venous thrombogenesis, (2) discusses the regulation of coagulation, (3) describes the pathways for testing new anticoagulant agents, (4) describes new anticoagulant strategies focusing primarily on agents in phase II or III clinical testing, and (5) provides clinical perspective as to which of these new strategies is most likely to succeed.

References

Oct 15, 1992·The Biochemical Journal·J I WittingJ W Fenton
Mar 19, 1992·The New England Journal of Medicine·B Furie, B C Furie
Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Jan 30, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Feb 1, 1991·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·I P Baskova, G I Nikonov
Oct 20, 1991·Journal of Molecular Biology·E Skrzypczak-JankunJ M Maraganore
May 30, 1991·The New England Journal of Medicine·J Hirsh
Oct 1, 1986·The Journal of Clinical Investigation·D C AltieriA M Capitanio
Aug 2, 1969·Lancet·V V KakkarM B Clarke
Sep 1, 1971·The British Journal of Radiology·A N NicolaidesJ T Renney
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·M CappelloP J Hotez
May 1, 1995·The Journal of Clinical Investigation·D T EitzmanD Ginsburg
Jan 1, 1993·Seminars in Thrombosis and Hemostasis·D Gailani, G J Broze
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·P StassensG P Vlasuk
Sep 12, 1996·The New England Journal of Medicine·UNKNOWN Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
Jan 1, 1996·Seminars in Thrombosis and Hemostasis·R B Wallis
Jun 1, 1996·Coronary Artery Disease·V ToschiJ H Chesebro
Oct 1, 1996·Critical Reviews in Clinical Laboratory Sciences·L MuszbekH Mikkola
May 30, 1997·The Journal of Biological Chemistry·D V SakharovD C Rijken
Jul 1, 1997·Clinical Pharmacology and Therapeutics·G LefèvreP Close
Jan 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·F J NeumannA Schömig
Jan 1, 1997·Seminars in Thrombosis and Hemostasis·M J HurstingR P Schwarz
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·P L GiesenY Nemerson
Jan 1, 1996·Journal of Thrombosis and Thrombolysis·J P HerrmanP W Serruys

❮ Previous
Next ❯

Citations

Aug 5, 2008·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Karen E A Burns, Andrew McLaren
Aug 27, 2005·Nature Clinical Practice. Cardiovascular Medicine·Detlef HeringDieter Horstkotte
May 7, 2009·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Manoefris KasimHosen Kiat
Aug 12, 2005·The Nurse Practitioner·Maryanne Crowther, Kimberly McCourt
Jun 10, 2010·Drug Design, Development and Therapy·Cecilia BecattiniGiancarlo Agnelli
Oct 20, 2005·Current Opinion in Cardiology·Simon J McRae, Jeffrey S Ginsberg
Mar 30, 2005·International Anesthesiology Clinics·Balachundhar Subramaniam, Kyung W Park
Mar 11, 2008·Expert Review of Cardiovascular Therapy·Victoria E Price, Anthony K C Chan
Mar 21, 2007·Expert Opinion on Investigational Drugs·Alex C Spyropoulos
Feb 2, 2006·Expert Opinion on Pharmacotherapy·William H Matthai
Oct 9, 2012·Best Practice & Research. Clinical Rheumatology·Savino SciasciaMaria Jose' Cuadrado
Oct 19, 2011·Bioorganic & Medicinal Chemistry Letters·Koneni V SashidharaMadhu Dikshit
Apr 15, 2006·Journal of Vascular and Interventional Radiology : JVIR·Rakesh P Mehta, Matthew S Johnson
Nov 6, 2008·Current Problems in Surgery·Thomas W WakefieldAnthony J Comerota
Apr 15, 2008·Cardiology Clinics·Daniel J Brotman, Amir K Jaffer
Dec 27, 2005·Clinics in Geriatric Medicine·Amir K Jaffer, Daniel J Brotman
Mar 8, 2005·Journal of Thrombosis and Haemostasis : JTH·G Di Pasquale, G Casella
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·C E Fadul, L R Zacharski
Mar 23, 2005·Pediatric Blood & Cancer·Vinod V Balasa
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·H R BullerS Middeldorp
Jul 29, 2006·Pharmacoepidemiology and Drug Safety·Surachai KotirumPonlapat Rojnuckarin
Nov 21, 2007·Journal of Clinical Pharmacy and Therapeutics·Y HassanO Ismail
Jan 19, 2011·British Journal of Clinical Pharmacology·Catherine J Lee, Jack E Ansell
Sep 6, 2006·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Wendy L Marr
Aug 18, 2005·Seminars in Hematology·Lawrence Rice
Aug 2, 2005·Thrombosis Research·J Ansell
Aug 9, 2005·European Journal of Internal Medicine·C J BoosG Y H Lip
Jul 5, 2005·Critical Care Clinics·Richard WhitlockHeng J Ng
Feb 26, 2013·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·N ProsA Bura
Jul 19, 2005·Expert Opinion on Investigational Drugs·Jeanine M WalengaJawed Fareed
Jan 30, 2015·Plastic and Reconstructive Surgery·Matthew L IorioSteven P Davison
Oct 27, 2016·Plastic and Reconstructive Surgery·Joseph A RicciMatthew L Iorio
Mar 10, 2017·Expert Review of Hematology·Or CarmiYair Levy
Aug 1, 2007·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·L YangA R Rezaie
Apr 26, 2007·Journal of Intensive Care Medicine·Stavros G MemtsoudisJ Matthias Walz
Apr 15, 2008·Cardiology Clinics·Edith A NutescuAimee Chevalier
Jan 30, 2007·Journal of Intensive Care Medicine·Frederick RogersRonald F Sing
May 5, 2006·Journal of Intensive Care Medicine·Setu K VoraDoruk Erkan
Aug 17, 2006·The Annals of Pharmacotherapy·Edith A NutescuWilliam E Dager

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.